Learn how to achieve the ideal concentration of chemotherapy drug in your system through our upcoming webinar. We're partnering with MyCare Diagnostics to bring you a discussion on better cancer care featuring Adrienne Choma, Co-founder and Chief Operating Officer of Saladax Biomedical Inc., the maker of My5-FU Chemotherapy Optimization Test.
As a cancer survivor herself, Adrienne will provide an overview of the support for customized dosing:
- Personalized dosing leads to optimized treatment outcomes and a reduction in the incidence and severity of toxic side effects associated with 5-FU chemotherapy.
- Very often dose adjustments are necessary to achieve target drug levels for each individual patient.
- Limitations of current methods of dosing.
- Variability in that no two patients are alike.
- Growing body of evidence supporting My5-FU blood testing to optimize the 5-FU level in each patient.